Frank Weathers, PhD

Research Professor, Psychiatry

Frank Weathers
617.414.1995
150 S Huntington Avenue

Publications

  • Published on 2/1/2024

    Parmenter ME, Lederman S, Weathers FW, Davis LL, Vaughn B, Engels J, Sullivan GM. A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder. Psychiatry Res. 2024 Apr; 334:115764. PMID: 38350291.

    Read at: PubMed
  • Published on 11/14/2023

    Lee DJ, Crowe ML, Weathers FW, Bovin MJ, Ellickson S, Sloan DM, Schnurr P, Keane TM, Marx BP. An Item Response Theory Analysis of the Clinician-Administered PTSD Scale for DSM-5 Among Veterans. Assessment. 2023 Nov 14; 10731911231202440. PMID: 37960836.

    Read at: PubMed
  • Published on 2/8/2023

    Reger GM, Smolenski D, Williams R, Norr AM, Foa E, Kuhn E, Schnurr PP, Weathers F, Zoellner L. Design and methods of a randomized controlled trial evaluating the effects of the PE Coach mobile application on prolonged exposure among veterans with PTSD. Contemp Clin Trials. 2023 Apr; 127:107115. PMID: 36758935.

    Read at: PubMed
  • Published on 1/23/2023

    Kramper S, Crosby ES, Waitz-Kudla SN, Weathers F, Witte TK. Highly stressful events and posttraumatic stress disorder symptoms among veterinary professionals: Prevalence and associations with mental health and job-related outcomes. Psychol Trauma. 2023 Sep; 15(Suppl 2):S275-S285. PMID: 36689377.

    Read at: PubMed
  • Published on 8/1/2022

    Kramer LB, Whiteman SE, Petri JM, Spitzer EG, Weathers FW. Self-Rated Versus Clinician-Rated Assessment of Posttraumatic Stress Disorder: An Evaluation of Discrepancies Between the PTSD Checklist for DSM-5 and the Clinician-Administered PTSD Scale for DSM-5. Assessment. 2023 Jul; 30(5):1590-1605. PMID: 35915927.

    Read at: PubMed
  • Published on 4/7/2022

    Lee DJ, Weathers FW, Thompson-Hollands J, Sloan DM, Marx BP. Concordance in PTSD symptom change between DSM-5 versions of the Clinician-Administered PTSD Scale (CAPS-5) and PTSD Checklist (PCL-5). Psychol Assess. 2022 Jun; 34(6):604-609. PMID: 35389681.

    Read at: PubMed
  • Published on 3/5/2022

    Bardeen JR, Gorday JY, Weathers FW. Executive functioning deficits exacerbate posttraumatic stress symptoms: A longitudinal mediation model. J Anxiety Disord. 2022 Apr; 87:102556. PMID: 35276509.

    Read at: PubMed
  • Published on 12/23/2021

    Marx BP, Lee DJ, Norman SB, Bovin MJ, Sloan DM, Weathers FW, Keane TM, Schnurr PP. Reliable and clinically significant change in the clinician-administered PTSD Scale for DSM-5 and PTSD Checklist for DSM-5 among male veterans. Psychol Assess. 2022 Feb; 34(2):197-203. PMID: 34941354.

    Read at: PubMed
  • Published on 9/1/2021

    Norrholm SD, Zalta A, Zoellner L, Powers A, Tull MT, Reist C, Schnurr PP, Weathers F, Friedman MJ. Does COVID-19 count?: Defining Criterion A trauma for diagnosing PTSD during a global crisis. Depress Anxiety. 2021 Sep; 38(9):882-885. PMID: 34469042.

    Read at: PubMed
  • Published on 4/30/2021

    Sullivan GM, Gendreau RM, Gendreau J, Peters P, Peters A, Engels J, Daugherty BL, Vaughn B, Weathers FW, Lederman S. Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response. Psychiatry Res. 2021 Jul; 301:113974. PMID: 33979763.

    Read at: PubMed

View 54 more publications: View full profile at BUMC

View all profiles